Fukuda T - Search Results

1

Impact of low-carbohydrate diet on renal function: a meta-analysis of over 1000 individuals from nine randomised controlled trials.

Oyabu C, Hashimoto Y, Fukuda T, Tanaka M, Asano M, Yamazaki M, Fukui M. Oyabu C, et al. Among authors: fukuda t. Br J Nutr. 2016 Aug;116(4):632-8. doi: 10.1017/S0007114516002178. Epub 2016 Jun 27. Br J Nutr. 2016. PMID: 27346534

2

Association between serum γ-glutamyltranspeptidase and atherosclerosis: a population-based cross-sectional study.

Fukuda T, Hamaguchi M, Kojima T, Ohshima Y, Ohbora A, Kato T, Nakamura N, Fukui M. Fukuda T, et al. BMJ Open. 2014 Oct 3;4(10):e005413. doi: 10.1136/bmjopen-2014-005413. BMJ Open. 2014. PMID: 25280803 Free PMC article.

3

Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study.

Fukuda T, Fukui M, Tanaka M, Senmaru T, Iwase H, Yamazaki M, Aoi W, Inui T, Nakamura N, Marunaka Y. Fukuda T, et al. Biomed Rep. 2015 May;3(3):355-360. doi: 10.3892/br.2015.436. Epub 2015 Feb 25. Biomed Rep. 2015. PMID: 26137235 Free PMC article.

4

The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.

Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. Fukuda T, et al. Liver Int. 2016 Feb;36(2):275-83. doi: 10.1111/liv.12912. Epub 2015 Jul 30. Liver Int. 2016. PMID: 26176710

5

BMI history and risk of incident fatty liver: a population-based large-scale cohort study.

Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, Kojima T, Fukui M. Hashimoto Y, et al. Among authors: fukuda t. Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1188-93. doi: 10.1097/MEG.0000000000000682. Eur J Gastroenterol Hepatol. 2016. PMID: 27347789

6

The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.

Hashimoto Y, Osaka T, Fukuda T, Tanaka M, Yamazaki M, Fukui M. Hashimoto Y, et al. Among authors: fukuda t. Endocr J. 2016 Oct 29;63(10):877-884. doi: 10.1507/endocrj.EJ16-0124. Epub 2016 Jul 9. Endocr J. 2016. PMID: 27397679

7

Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.

Yoshitaka H, Hamaguchi M, Kojima T, Fukuda T, Ohbora A, Fukui M. Yoshitaka H, et al. Among authors: fukuda t. Medicine (Baltimore). 2017 May;96(18):e6712. doi: 10.1097/MD.0000000000006712. Medicine (Baltimore). 2017. PMID: 28471965 Free PMC article.

8

Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.

Hashimoto Y, Hamaguchi M, Fukuda T, Ohbora A, Kojima T, Fukui M. Hashimoto Y, et al. Among authors: fukuda t. Endocrine. 2017 Jul;57(1):89-97. doi: 10.1007/s12020-017-1313-6. Epub 2017 May 16. Endocrine. 2017. PMID: 28508194

9

Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.

Mitsuhashi K, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukuda T, Fukui M. Mitsuhashi K, et al. Among authors: fukuda t. Endocr J. 2017 Nov 29;64(11):1105-1114. doi: 10.1507/endocrj.EJ17-0245. Epub 2017 Sep 2. Endocr J. 2017. PMID: 28867686

10

Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individuals.

Hashimoto Y, Hamaguchi M, Fukuda T, Obora A, Kojima T, Fukui M. Hashimoto Y, et al. Among authors: fukuda t. Endocrine. 2017 Nov;58(2):253-261. doi: 10.1007/s12020-017-1411-5. Epub 2017 Sep 30. Endocrine. 2017. PMID: 28965186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results